---

$11.00

-0.0050 ( -0.23% ) 550.9K

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-06-05	Sale	-17600.00	BIENAIME JEAN JACQUES
2024-06-03	Sale	-10000.00	Kariv Tomer
2024-06-03	Sale	-10000.00	Knowles Julius
2024-06-03	Sale	-10000.00	GRAY MARY ANN
2024-06-03	Sale	-10000.00	GORDON CARL L
2024-06-03	Sale	-10000.00	Farzan Nima
2024-06-03	Sale	-10000.00	Nussbaum Ran
2024-06-03	Sale	-10000.00	Seth Alpna
2024-02-23	Sale	-125000.00	Seehra Jasbir
2024-02-15	Sale	-125000.00	Seehra Jasbir

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.